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Abstract
Painful stimuli are of utmost behavioral relevance and thereby affect attentional resources. In health, variable effects of pain
on attention have been observed, indicating alerting as well as distracting effects of pain. In the human brain, these effects
are closely related to modulations of neuronal gamma oscillations. As hypervigilance as an abnormal increase of attention
to external stimuli has been implicated in chronic pain states, we assumed both attentional performance and pain-induced
gamma oscillations to be altered in patients with fibromyalgia syndrome (FMS). We recorded electroencephalography from
healthy subjects (n=22) and patients with FMS (n=19) during an attention demanding visual reaction time task. In 50% of
the trials we applied painful laser stimuli. The results of self-assessment questionnaires confirm that patients with FMS
consider themselves hypervigilant towards pain as compared to healthy controls. However, the experimental findings
indicate that the effects of painful stimuli on attentional performance and neuronal gamma oscillations do not differ
between patients and healthy subjects. We further found a significant correlation between the pain-induced modulation of
visual gamma oscillations and the pain-induced modulation of reaction times. This relationship did not differ between
groups either. These findings confirm a close relationship between gamma oscillations and the variable attentional effects
of pain, which appear to be comparable in health and disease. Thus, our results do not provide evidence for a behavioral or
neuronal manifestation of hypervigilance in patients with FMS.
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Introduction
In health, pain fulfills a vital warning function to prevent
physical harm. Due to this particular biological salience, painful
stimuli involuntarily affect the allocation of attentional resources
[1,2]. On the one hand, prioritized processing of pain may affect
the simultaneous processing of competing non-painful stimuli.
Although somewhat controversial [3–5], there is substantial
evidence that pain interferes with ongoing behavior by demanding
the limited resources of selective attention ([6–9], for review see
[1,10,11]). On the other hand, these distracting effects of pain are
complemented by alerting effects [12,13]. In line with these
findings, several studies in healthy subjects observed variable
effects of pain on behavioral performance, with painful stimulation
yielding increased reaction times for some, as well as decreased
reaction times for other subjects [14,15]. In the human brain,
these effects are closely related to modulations of neuronal gamma
oscillations (30–100 Hz, [15,16]).
In chronic pain states, pain does no longer fulfill a protective
function, but represents a pathological condition with devastating
effects on quality of life. Dysfunctional attentional processes have
been implicated in the pathogenesis of chronic pain syndromes
[1,17]. In patients with fibromyalgia syndrome (FMS), hypervig-
ilance as an abnormal increase of attention to external stimuli has
been inferred from an increase in sensitivity to a large variety of
painful [18–23] and non-painful stimuli [24–29]. Alternatively,
but not mutually exclusively, a central augmentation of sensory
input in terms of central sensitization [30] or deficient inhibitory
control mechanisms [31,32] may also account for the hypersen-
sitivity in FMS. Experimentally, hypervigilance can be assessed
using a behavioral paradigm inducing attentional interference [6].
Using such a primary task paradigm, evidence for behaviorally
relevant hypervigilance in patients with chronic pain has been
reported [33]. On the other hand, several experimental investi-
gations failed to find experimental evidence for hypervigilance in
patients with FMS [34,35]. Thus, the existent literature is
inconclusive, albeit not unsuggestive of hypervigilance in FMS.
Accordingly, the role of hypervigilance in FMS remains to be
elucidated.
We therefore recorded electroencephalography (EEG) during a
visual attention task with concurrent painful stimulation to
characterize both pain-related attentional performance and pain-
induced neuronal gamma oscillations of patients with FMS and
healthy subjects. Specifically, we aimed to address the following
questions: (1) Do patients with FMS display a more pronounced
pain-related distraction in an attention demanding paradigm as a
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35068behavioral correlate of hypervigilance towards pain? (2) Do
patients with FMS and healthy subjects differ regarding visual
and pain-induced gamma oscillations as a neuronal correlate of
the attentional effects of pain? (3) Do patients with FMS and
healthy subjects differ regarding the relationship between pain-
induced effects on behavioral performance and pain-induced
effects on neuronal gamma oscillations?
Materials and Methods
Subjects
The patient sample included data of 19 subjects (5 male, 14
female) with a mean age of 52 years (range 24–71 years). Patients
were recruited from the Department of Physical Medicine and
Rehabilitation, Klinikum der Universita ¨t Mu ¨nchen, and the
Department of Psychosomatic Medicine and Psychotherapy,
Technische Universita ¨t Mu ¨nchen. The inclusion criterion was
fulfilling the American College of Rheumatology (ACR) criteria
for FMS [36]. These require: (1) widespread pain involving both
sides of the body, present above and below the waist as well as
along the axial skeletal system, for at least three months. (2) Pain in
11 of 18 tender points on digital palpation. Exclusion criteria
comprised neurologic, psychiatric, dermatological, or metabolic
diseases, any disease causing chronic or acute pain other than
FMS, and inability to interrupt therapy with centrally active
analgesics (opioids) or coanalgesics (antidepressants, anticonvul-
sants) for a minimum of 7 days. The use of peripherally active
rescue analgesics was allowed for up to 24 hours before study
participation.
Additionally, 22 healthy subjects (2 male, 20 female) with a
mean age of 47 years (range 25–66 years) participated in the study.
Control and patient sample were matched for age (t=1.4, p.0.1)
and sex (x
2=2.1, p.0.1).
Written informed consent was obtained from all patients and
healthy subjects before participation. The procedure was approved
by the institutional review board (Ethikkommission der Tech-
nischen Universita ¨t Mu ¨nchen) and conducted in conformity with
the declaration of Helsinki.
Procedure
Participants completed an attention-demanding visual reaction
time task with interfering painful laser stimuli to investigate the
effects of pain on attention (Fig. 1). The visual attention task is
based on a well-established paradigm [15,37] which reliably
induces gamma oscillations in human visual cortices.
Subjects were presented a white fixation point against black
background. After 2000 ms a circular sine wave grating
contracting towards its center was shown. After a pseudorandomly
varied duration of 1200 to 2500 ms the contraction accelerated,
signaling the subjects to press a button with their right hand as fast
as possible. Visual feedback followed the response. In 50% of the
trials painful stimuli were applied to the left hand (pain trials).
Apart from the application of painful stimuli, pain and no pain trials
were identical. Time of painful stimuli was varied with respect to
the onset of visual stimulation to avoid predictability of painful
stimuli. Each subject completed one block consisting of 168 trials
with a total duration of approximately 18 minutes. Subjects were
instructed to complete the visual task without becoming distracted
by the painful stimulation.
Prior to the EEG recordings, individual pain thresholds were
determined using the method of limits. After the EEG recordings,
subjects were asked to rate the mean pain intensity on a visual
analogue scale. The scale ranged from 0 to 10, with 0 representing
‘‘no pain’’ and 10 representing ‘‘maximum tolerable pain’’. The
anchor descriptors no pain/maximum tolerable pain were chosen
because they can be expected to yield a broader range of ratings in
experimental studies in which low to moderate pain intensities are
used, thereby yielding a higher sensitivity of ratings. In addition,
we assessed pain vigilance and pain catastrophizing by using
German versions of well-established questionnaires (Pain vigilance
and awareness questionnaire, PVAQ [38]; Pain catastrophizing
scale, PCS [39]).
Stimuli
The task was performed on a personal computer with a 19 inch
CRT monitor and a vertical refresh rate of 60 Hz using E-Prime
software (Version 1.2, Psyc. Tools Inc.). Subjects were seated at a
distance of approximately 70 cm from the computer screen.
Painful stimuli were delivered to the dorsum of the left hand
using a Tm:YAG laser (Starmedtec GmbH, Starnberg, Germany)
with a wavelength of 1960 nm, a pulse duration of 1 ms and a spot
diameter of 5 mm. A distance pin mounted on the hand piece of
the laser device ensured a constant distance between skin surface
and laser device. Stimulation site was slightly varied after each
stimulus. Stimulus intensity was individually adjusted to match a
rating of 5 on a numerical rating scale ranging from 0 (‘‘no pain’’)
to 10 (‘‘maximum tolerable pain’’). Subjects were exposed to white
noise through headphones to cancel out noise of the laser device.
EEG recordings
EEG data were recorded with an electrode cap (Easycap,
Herrsching, Germany) and BrainAmp MR plus amplifiers (Brain
Products, Munich, Germany) using the BrainVision Recorder
software (Brain Products, Munich, Germany). Electrode montage
included 64 electrodes consisting of the electrodes Fz/Cz/Pz,
FP1/2, F3/4/7/8, C3/4, P3/4, T3/4/5/6 and O1/2 of the 10–
20 system and the additional electrodes FPz, AFz, FCz, CPz, POz,
Oz, Iz, AF3/4, F5/6, FC1/2/3/4/5/6, FT7/8/9/10, C1/2/5/6,
CP1/2/3/4/5/6, P1/2/5/6, TP7/8/9/10, and PO3/4/7/8/9/
10. Two more electrodes were fixed below the outer canthi of the
eyes. The EEG was referenced to the FCz electrode, grounded at
AFz, sampled at 1000 Hz and highpass-filtered at 0.1 Hz. The
impedance was kept below 20 kV.
Figure 1. Paradigm. Subjects were presented a white fixation point
against black background. After 2000 ms a circular sine wave grating
contracting towards its center was shown. After a pseudorandomly
varied duration of 1200 to 2500 ms the contraction accelerated,
signaling the subjects to press a button with their right hand as fast
as possible. Visual feedback followed the response. In 50% of the trials
painful stimuli were applied to the left hand (pain trials). Apart from the
application of painful stimuli, pain and no pain trials were identical.
Time of painful stimuli was varied with respect to the onset of visual
stimulation to avoid predictability of painful stimuli. Subjects were
instructed to complete the visual task without becoming distracted by
the painful stimulation.
doi:10.1371/journal.pone.0035068.g001
No Evidence for Hypervigilance in FMS
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Behavioral Data. To determine the effects of pain on visual
task performance, reaction times were registered on a trial-by-trial
basis. With regard to nerve conduction velocities, visual reaction
times less than 150 ms were considered as false alarms and
excluded from further analyses. Likewise, reaction times greater
than 500 ms were considered as attentional errors and excluded
from the analysis [40,41]. This resulted in a total of 380 excluded
trials (19%; pain trials: 222, no pain trials: 161). To compare the
number of excluded trials between groups and conditions, we
calculated a mixed model ANOVA with group as between- and
condition as within-subject factor. The results do not show a
significant interaction between group and condition (F[1,39]=0.3,
p=0.6), indicating that in the patient and the control group a
comparable number of pain- and no pain-trials were excluded. For
each subject, mean reaction times of pain and no pain trials were
calculated and compared. Since reaction times [42] and
neurophysiological responses [43] to painful stimuli are mainly
observed between 100 and 500 ms after stimulus application, we
expected painful stimuli which are applied shortly before a
required response to interfere most profoundly with visual task
performance. Analysis of behavioral data was therefore focused on
pain trials where laser stimuli were applied during this time interval
(200 or 500 ms before the acceleration, n=24) and compared to
otherwise identical no pain trials (n=24).
Preprocessing of EEG data. EEG data were preprocessed
using the BrainVision Analyzer software (Brain Products, Munich,
Germany). Offline analysis included downsampling to 512 Hz,
digital highpass filtering at 0.5 Hz and recomputation to the
average reference. Downsampling included automatic lowpass
filtering at 230 Hz. Independent component analysis was used to
correct for vertical and horizontal eye movements. Trials with
artifacts exceeding 6100 mV in any channel were automatically
rejected.
Time-frequency analysis of EEG data. Since reaction
times [42] and neurophysiological responses [43] to painful
stimuli are mainly observed between 100 and 500 ms after
stimulus application, analysis of behavioral responses focused on
this interval. However, these trials are inevitably contaminated by
motor activity related to the button press, which occurs shortly
after the painful stimulation in these trials. We therefore focused
the analysis of neurophysiological responses on pain trials where
button presses occur at least 1800 or 2000 ms after the pain stimuli
(n=60). This ensures a long interval for the neurophysiological
analysis, which is not contaminated by motor activity. It is
important to note that the trials chosen for behavioral and
neurophysiological analysis are identical except for the onset of
acceleration of the moving visual stimulus. Since we were
interested in the neuronal mechanisms before the acceleration, we
assume both behavioral and neurophysiological trials to be
identical concerning the pain-induced neuronal responses prior
to the acceleration. The pain trials (n=60) were compared to
otherwise identical no pain trials (n=60).
In order to transform the data from the time to the time-
frequency domain, the complex demodulation procedure imple-
mented in BESA 5.2 was used. Time-frequency transformation
was performed for frequencies from 4 to 100 Hz in a time window
from 21000 ms to 3500 ms with respect to the onset of visual
stimulation. Frequencies were sampled in steps of 2 Hz, latencies
in steps of 25 ms. Time-frequency representations were calculated
as % signal change with respect to baseline. In the no pain
condition, baseline was defined as 2800 to 2100 ms prior to
stimulus onset. In the pain condition, trials had to be realigned to
the laser stimuli that were applied either 500 or 700 ms after onset
of the visual stimulation. Thus, the beginning of visual stimulation
was preponed for 200 ms in 50% of the trials, and the baseline was
adjusted accordingly. The time-frequency transformed data were
averaged across trials for each condition and each electrode.
Source localization. The Multiple Source Beamformer Tool
implemented in BESA was used to localize the cerebral sources of
the visual and pain-induced gamma oscillations in each subject.
Strongest gamma responses to visual stimuli were observed at
latencies between 150 and 2500 ms and at frequencies between 48
and 54 Hz. Thus, localization was based on this time-frequency
window and compared to a 1000 ms baseline. Strongest gamma
responses to painful stimuli were observed at latencies between 75
and 200 ms after application of laser stimuli and at frequencies
between 34 and 56 Hz. Thus, localization was based on this time-
frequency window and compared to a 125 ms prestimulus baseline
including visual activation. The resulting individual activation
maps were averaged across subjects using BrainVoyager QX 1.9
(Brain Innovation, Maastricht, Netherlands).
Statistical analysis. Statistical analyses were performed
using PASW (former SPSS) for windows (release 18, SPSS Inc.,
Chicago). Means between groups were compared using t-tests.
Means between conditions and groups were compared using
mixed-model analyses of variance (ANOVAs) with group as a
between-subject factor and condition as a within-subject factor.
Correlations were calculated using Spearman’s rank correlation
coefficient. Correlation coefficients were compared between
groups by first converting each correlation coefficient into a z-
score using Fisher’s r-to-z transformation [44] and then calculating
a z-score of the difference.
Results
Behavioral effects of pain
Mean objective stimulus intensity of painful laser stimuli across
all participants was 528 mJ (SD=86 mJ; range 320–700 mJ).
These painful stimuli induced moderately painful sensations with a
mean rating of 5.7 (SD=1.8, range 2.0–9.4). Stimulus intensity
(t=21.08, p=0.3) and pain ratings (t=1.16, p=0.3) did not
differ between patients and healthy subjects. Though not
statistically significant, a trend towards lower pain thresholds was
noted in the patient group (t=21.9, p=0.07). Reaction times in
the visual task served as a measure of visual attention. Mean
reaction times across all trials were 361633 ms (mean 6 SD) for
healthy subjects and 373627 ms (mean 6 SD) for patients with
FMS. Reaction times across conditions did not differ between
groups (t=1.3, p=0.2). Differences in reaction times between
conditions served as measure of attentional interference. Painful
stimuli did not homogeneously affect visual reaction times but
yielded an increase of reaction times for some, as well as a decrease
of reaction times for other participants (Fig. 2). In healthy subjects,
these variable effects of pain on behavior have already been noted
in previous studies on pain-cognition interactions ([14,15], for
review see [2]). In patients with FMS, we hypothesized a priori
that the effects of pain on visual reaction times would be altered as
an expression of disease-specific dysfunctional attentional process-
es. However, a two-way repeated measures ANOVA with one
between subjects factor and one within subjects factor demon-
strated no significant main effect of group (F[1,39]=1.73, p=0.2)
or condition (F[1,39]=1.98, p=0.17). Moreover, the analysis did
not reveal a significant condition x group interaction
(F[1,39]=0.73, p=0.4). Thus, healthy subjects and patients with
FMS do not differ concerning the effects of pain on reaction time
as a measure of attentional interference.
No Evidence for Hypervigilance in FMS
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reaction times were not correlated with pain threshold (r=20.24,
p=0.13) or stimulus intensity (r=0.06, p=0.73). To control for
differences in the individual attentional bias towards pain, we
further considered the individual scores in the PVAQ as a measure
of pain vigilance [1] and the PCS [45] as measure of pain
catastrophizing. Patients with FMS considered themselves signif-
icantly more vigilant towards pain (t=4.62, p,0.001) and showed
a more pronounced tendency for catastrophizing (t=4.53,
p,0.01) compared to healthy subjects. However, the correlation
between the effects of pain on attentional performance and pain
vigilance/pain catastrophizing was not significant (r=0.06,
p=0.71/r=20.16, 0.30).
Visual and pain-induced gamma oscillations
Next, we investigated the effects of visual and painful stimuli on
neuronal activity in the gamma frequency range. At occipital
electrodes we found an increase in gamma oscillations which
started about 150 ms after the onset of visual stimulation and
lasted for the whole period of stimulus presentation (Fig. 3).
Frequency of visual gamma oscillations varied interindividually
between 40 and 60 Hz. The signal change was most prominent at
electrodes POz, Oz, PO3/4 and O1/2. At these electrodes,
gamma activity during visual stimulation (150 to 2500 ms, 48–
54 Hz) was significantly increased compared to a prestimulus
baseline (F[1,39]=45.2, p,0.001). The strength of visual gamma
oscillations did not differ between healthy subjects and patients
with FMS (F[1,39]=0.18, p=0.7). At central electrodes, we found
an increase in gamma oscillations between 75 and 200 ms after
application of painful laser stimuli and at frequencies between 34
and 56 Hz (Fig. 3). The oscillations were most prominent at
electrodes Cz and C2. At these electrodes, gamma activity was
significantly increased after painful stimulation (75 to 200 ms, 34–
56 Hz) compared to a prestimulus baseline (F[1,39]=7.9,
p=0.008). The strength of pain-induced gamma oscillations did
not differ between healthy subjects and patients with FMS
(F[1,39]=0.95, p=0.34). Visual gamma oscillations were localized
to the left and right occipital cortices (mean Talairach coordinates:
left 225, 293, 24; right 27, 286, 27; Fig. 4). A maximum of
pain-induced gamma oscillations was localized to the right
primary somatosensory cortex (mean Talairach coordinates: 32,
220, 35; Fig. 4).
Thus, painful and visual stimuli can induce gamma oscillations
in the somatosensory and visual system, respectively. Healthy
subjects and patients with FMS do not differ concerning the
strength of these visual and pain-induced gamma oscillations.
Relationship between the behavioral and neuronal
effects of pain in patients with FMS and healthy subjects
Next, we investigated the behavioral relevance of neuronal
gamma oscillations. If gamma oscillations are functionally relevant
for attentional selection and enhanced processing of visual
information, pain-induced changes in gamma oscillations would
be correlated with pain-induced changes in behavior. We
therefore correlated the effects of pain on visual reaction times
with the effects of pain on visual gamma oscillations. The analysis
revealed a significant positive correlation. Lower amplitudes of
visual gamma oscillations after painful laser stimulation were
associated with slower reaction times (r=0.4, p=0.01; Fig. 5),
indicating a significant relationship between the pain-induced
modulation of gamma oscillations in the human brain and the
pain-induced modulation of attentional performance in a visual
attention task.
We further investigated whether the correlation between the
behavioral and neuronal effects of pain differed between healthy
subjects and patients with FMS. We therefore compared the
correlations after transforming the correlation coefficients from r
to z-scores using Fisher’s z transformation. The comparison
revealed no significant difference of correlations between the
control and patient group (z=20.2, p=0.84).
Relationship between pain-induced and visual gamma
oscillations in patients with FMS and healthy subjects
We were next interested whether pain-induced gamma
oscillations in the somatosensory system affect visual gamma
oscillations in the visual system. We therefore correlated pain-
induced gamma oscillations at central electrodes (Cz, C2; 75–
200 ms after painful stimulation) with pain-induced changes of
visual gamma oscillations at occipital electrodes (Oz, POz, O1/2,
PO3/4; 200–350 ms after painful stimulation). This correlation
was not significant (r=20.11, p=0.5). However, previous studies
indicated that visual gamma oscillations in the right, but not left,
visual cortex are correlated with pain-induced gamma oscillations
at central electrodes [15]. Moreover, visual gamma oscillations
appeared to be right-lateralized (Fig. 3). Thus, we correlated pain-
induced gamma oscillations at central electrodes (Cz, C2) with
pain-induced changes of visual gamma oscillations at an electrode
over the right occipital cortex (PO4). This analysis revealed a
significant correlation (r=20.34, p=0.03; Fig. 6). Next, we were
Figure 2. Behavioral results. A Single-subject reaction times for each
group and condition. Please note that ascending lines connecting the
no pain and pain conditions indicate a pain-induced prolongation of
reaction times whereas descending lines indicate a reduction of
reaction times. B Mean reaction times for each group and condition.
doi:10.1371/journal.pone.0035068.g002
No Evidence for Hypervigilance in FMS
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somatosensory and visual system differed between healthy subjects
and patients with FMS. The comparison revealed no significant
difference of correlations between the control and patient group at
occipital electrodes of both hemispheres (z=0.3, p=0.76) or the
right hemisphere (z=1.29, p=0.2).
Thus, painful stimuli proportionally affect neuronal gamma
oscillations in the somatosensory and visual system of the
contralateral hemisphere. This relationship can likewise be
observed in both healthy subjects and patients with FMS.
Discussion
In the present study we investigated pain-related attentional
interference and its neuronal correlates in patients with FMS.
Referring to our initial questions, our results do not show a
difference between healthy subjects and patients with FMS in (1)
the effects of painful stimulation on reaction times, (2) the effects of
painful stimulation on visual and pain-induced gamma oscillations,
or (3) the relationship between pain-induced effects on behavioral
performance and pain-induced effects on neuronal gamma
oscillations. Thus, our findings do not show behavioral or
neuronal effects of hypervigilance in patients with FMS.
Figure 3. Visual and pain-induced gamma oscillations. The time-frequency-representations show group mean neuronal activity (% signal
change) in pain trials used for neurophysiological analysis, averaged across central (Cz, C2) and occipital (POz, Oz, PO3/PO4, O1/O2) electrodes. Data
are aligned to the onset of laser stimulation, which occurred 500 or 700 ms after onset of the visual stimulation, respectively. The topographic maps
show the scalp distribution of gamma oscillations following visual (150–2500 ms after onset of visual stimulation, 48–54 Hz) and painful (575–700 ms
after onset of visual stimulation, 75–200 ms after painful stimulation, 34–56 Hz) stimulation coded as % signal change as compared to baseline.
doi:10.1371/journal.pone.0035068.g003
Figure 4. Source localization of visual and pain-induced
gamma oscillations. Activations are maxima of mean activation
maps superimposed on a normalized surface-rendered structural T1-
weighted magnetic resonance image. Color-coded is the change of
estimated activity in the target interval relative to the baseline in %.
doi:10.1371/journal.pone.0035068.g004
Figure 5. Relationship between pain-induced changes in visual
gamma oscillations and pain-induced changes in visual task
performance. Displayed is the correlation between the signal change
of visual gamma oscillations (signal changeno pain – signal changepain)a t
occipital electrodes, and the change of reaction times after painful laser
stimulation (RTpain –R T no pain). Stronger pain-related modulations of
visual gamma oscillations are associated with stronger pain-related
modulations of reaction times.
doi:10.1371/journal.pone.0035068.g005
No Evidence for Hypervigilance in FMS
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Neuronal gamma oscillations have been related to attentional
selection and enhanced processing of sensory information [46–48].
Here, we recorded pain-induced and visual gamma oscillations as
neuronal correlates of visual and pain-related selective attention
during a visual attention task with painful stimulation. To our
knowledge, this is the first study to compare gamma oscillations as
a neuronal signature of selective attention in healthy subjects and
patients with FMS. However, healthy subjects and patients with
FMS did not differ concerning their attentional performance or
the strength of visual or pain-induced gamma oscillations. Due to
the lack of a behavioral effect, however, it can not be excluded that
gamma oscillations might represent a neuronal correlate of
hypervigilance in situations where patients with FMS display
behavioral signs of hypervigilance compared to healthy controls.
Pain-related reallocation of visual and pain-induced
gamma oscillations
In accordance with the hypothesis of limited attentional
capacity, we expected simultaneous visual and painful stimulation
to induce a reallocation of visual and pain-induced gamma
oscillations in the human brain. Indeed, we observed a correlation
between the strength of pain-induced gamma oscillations at central
electrodes and the pain-induced modulation of visual gamma
oscillations at occipital electrodes, indicating a proportional pain-
related reallocation of gamma oscillations from visual to central
areas. It has, however, to be noted that this correlation can not be
interpreted as evidence for functional connectivity between these
two areas. Still, the finding is in accordance with the results of a
previous study using the same paradigm in a sample of healthy
subjects [15]. In accordance with the hypothesis of dysfunctional
attentional processes in FMS, either a disruption or a strength-
ening of the relationship between visual and pain-induced gamma
oscillations would have been conceivable. However, a comparison
of correlations between the patient and control group yielded no
significant result, indicating that an inversely proportional
reallocation of visual and pain-induced gamma oscillations can
be likewise observed in healthy subjects and patients with FMS.
Gamma oscillations as a neuronal correlate of the
attentional effects of pain
In the present study we observed a significant correlation
between the pain-induced effects on gamma oscillations and
reaction times, respectively. This finding confirms a close
relationship between gamma oscillations and reaction times as a
measure of attentional performance [15,49–52]. Here, we were
particularly interested in whether the relationship between gamma
oscillations and behavioral performance differed between patients
with FMS and healthy subjects as an expression of pathologically
altered attentional processing in FMS. However, we found the
relationship between neuronal gamma oscillations and behavioral
performance to be comparable in patients and healthy subjects.
Hypervigilance in FMS does not affect behavioral
performance or neuronal processing
The concept of hypervigilance in FMS gives reason to expect
that patients are more easily distracted by painful stimulation and
perform worse than healthy subjects in a behavioral paradigm
inducing attentional interference. Our results confirm that patients
consider themselves significantly more vigilant towards pain than
healthy subjects. However, behavioral performance could not
confirm an attentional bias towards pain in patients with FMS.
In health, variable effects of pain on behavior have been
repeatedly described [14,15]. This interindividual variability in the
reaction to pain could not be attributed to differences in stimulus
intensity or to differences in psychological factors [15]. Semino-
wicz and colleagues [14] proposed that the behavioral variability
may relate to individual differences in the utilization of cognitive
coping strategies. Moreover, it was suggested that differences in
the balance of distracting and alerting effects of pain on attention
may result in a behavioral continuum with varying grades from
pain-induced decreased to pain-induced increased performance
[15]. In conformity with this hypothesis, dysfunctional attentional
processes in FMS might correspond to a shift in the balance of
distracting and alerting effects of pain towards the hypervigilant
pole of this continuum. Here, however, we observed a comparable
variability in the attentional effects of pain in the patient and the
control group. Thus, our results do not show dysfunctional
attentional processing of pain in patients with FMS.
Using self-assessment-questionnaires our results confirm that
FMS patients consider themselves as hypervigilant towards pain
which is in good agreement with the literature [27,28,53].
However, self-reported hypervigilance did not manifest itself in
behavioral performance or neuronal processing. Likewise, the
literature reports inconsistent results when hypervigilance in FMS
is tested experimentally. On the one hand, at least one study
reports evidence for behaviorally relevant attentional interference
in patients with chronic pain [33]. In this study, the performance
of chronic pain patients in an attention-demanding cognitive task
was evaluated. The results showed that the disruption of
attentional performance was most pronounced in patients with
high pain intensity. However, the study sample comprised patients
suffering from chronic pain of various origins and did not include a
control group. Thus, the observed effects may not be specific to
chronic pain in general or FMS in particular. On the other hand,
several experimental investigations failed to find any evidence for
behaviorally relevant hypervigilance in patients with FMS
([34,35], for review see [54]). Whereas those studies evaluated
the attentional bias regarding innocuous somatosensory [35] or
threatening linguistic stimuli [34], the present study is the first to
assess the pain-related attentional bias in FMS using a behavioral
paradigm with concurrent painful stimulation, which is well suited
Figure 6. Relationship between pain-induced gamma oscilla-
tions and pain-induced changes in visual gamma oscillations.
Displayed is the correlation between the signal change of pain-induced
gamma oscillations measured 75–200 ms after painful laser stimulation
at central electrodes and the signal change of visual gamma oscillations
measured 200–350 ms after painful laser stimulation at occipital
electrodes (signal change occipitalno pain – signal change occipitalpain).
doi:10.1371/journal.pone.0035068.g006
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evidence for a behavioral or neuronal correlate of self-reported
hypervigilance.
Decreased heat and pressure pain thresholds in FMS have been
consistently reported by investigations using sensory testing
methods [18–21,23,55–57]. In the present study, a tendency for
lowered laser pain thresholds in the patient group could be noted.
Considering the lack of a behavioral or neuronal correlate of
hypervigilance in our study sample, one may speculate that these
increases in pain sensitivity may not be due to hypervigilance for
pain. Alternatively, but not mutually exclusively, central sensiti-
zation has been implicated in the pathophysiology of FMS (for
review see [30]).
Limitations
The generalizability of the present findings is limited in several
aspects. First, behavioral studies have revealed that the capture of
attention by pain is enhanced whenever pain is perceived as
particularly threatening [1,9]. Here, we did not control for the
individual level of threat of the painful stimulation. Thus, it can
not be precluded that patients with FMS are susceptible for pain-
related attentional interference whenever the threat of painful
stimulation is particularly high. Moreover, the clinical relevance of
the experimental painful stimulation is debatable. The extent of
attentional interference induced by brief, painful laser stimulation
may not necessarily correspond to the extent of attentional
interference induced by chronic pain experienced in FMS. Finally,
it has been shown that the extent of pain-related distraction is
related to the difficulty of the primary task [58–60]. Hence, it can
not be excluded that the choice of paradigm accounts for the lack
of behaviorally-relevant attentional interference in both patients
and healthy controls. Conclusively it can be stated that the results
obtained with the present paradigm and stimulation method do
not necessarily generalize to other experimental or clinical settings.
Conclusions
Using a behavioral paradigm to study attentional interference,
we observed comparable task performance in patients and healthy
controls. In both the patient and the control group, attentional
effects of pain on behavioral performance were closely related to
gamma oscillations in the human brain. However, since these
effects did not differ between patients and healthy subjects, we
could not confirm gamma oscillations as a neuronal correlate of
perceived hypervigilance in FMS. The fact that perceived
hypervigilance in patients with FMS does not manifest itself in
behavioral performance and/or neuronal processing argues
against a critical role of dysfunctional attentional processes in
the pathogenesis of the disease. However, in order to conclusively
assess the generalizability of the present findings, future studies
taking into account the effect of stimulus qualities and paradigm
characteristics are needed.
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